Alba Llop Guevara

Title: Alba Llop Guevara: Innovator in Cancer Treatment Methods

Introduction

Alba Llop Guevara is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of oncology through his innovative methods for detecting RAD51 foci in tumor cells. His work aims to improve the sensitivity and resistance assessment of cancer treatments.

Latest Patents

Alba Llop Guevara holds 1 patent for his invention titled "Methods based on the detection of RAD51 foci in tumor cells." This invention provides a method that allows healthcare professionals to determine whether a subject diagnosed with cancer is sensitive or resistant to anti-cancer treatments. The method is based on the level of cells with RAD51 foci in a sample containing tumor cells isolated from the subject, ensuring that the subject has not received specific chemotherapy treatments within 24 hours prior to sample isolation.

Career Highlights

Throughout his career, Alba has worked with prominent organizations, including the Fundació Privada Institut d'Investigació Oncològica de Vall Hebron and AstraZeneca U.K. Limited. His experience in these institutions has contributed to his expertise in cancer research and treatment methodologies.

Collaborations

Alba has collaborated with esteemed colleagues such as Violeta Serra Elizalde and Judith Balmaña Gelpi. Their joint efforts in research have further advanced the understanding of cancer treatment responses.

Conclusion

Alba Llop Guevara's innovative work in cancer treatment methods highlights his commitment to improving patient outcomes. His contributions to the field of oncology are invaluable and continue to influence cancer research and treatment strategies.